@Shan74 no problem.
If I had to take a stab at the dark guess I think that mangment are keeping everything close to their chest for an investor presentation.
There has been at least 1 harvests (maybe 2 or 3) since we last heard crop figures.
I can't imagine management have nothing to report on.
There is also Canntab and Pharmocann products also which I have no doubt will be in production soon. A few people have said they won't make any money here with medical cannabis products but that isn't relevant at the moment because if you read announcements properly you would know that they are producing them to be exported to Asia and Europe.
Pharmocann products couldn't be exported out of Israel due to government restrictions on exporting and Canntab don't have an export license (to the best of my knowledge).
Just sit back and wait for the investors presentation which mangment have said will be out prior to trade opening. See what they have to offer then panic lol.
- Forums
- ASX - By Stock
- CGB
- Ann: Thirteenth Supplementary Prospectus
Ann: Thirteenth Supplementary Prospectus, page-276
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online